NCT05081193 2025-09-22
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
Clinical Trials
5 trialsNCT04049331 2025-03-11
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Seattle Institute for Biomedical and Clinical Research
Phase 2 Recruiting
NCT02966652 2019-11-26
Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism
Neurocrine UK Limited
Phase 1 Completed
NCT03379012 2019-10-22
FARETES
Kidney Cancer Research Bureau
Phase 2 Completed
NCT01206270 2018-09-25
ALCeP
University of Roma La Sapienza
Phase 2/3 Completed